• Skip to main content
  • Skip to after header navigation
  • Skip to site footer
ERN: Emerging Researchers National Conference in STEM

ERN: Emerging Researchers National Conference in STEM

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Conference
  • Abstracts
    • Undergraduate Abstract Locator
    • Graduate Abstract Locator
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
  • Travel Awards
  • Resources
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • Login

Prospects of IR-780 as an Imaging Dye for Enhanced Prostate Cancer Diagnosis via High-Density Lipoproteins

Undergraduate #308
Discipline:
Subcategory: Cancer Research

Jala Redmon - Alabama State University
Co-Author(s): Bhavani Natarajan, Nirupama Sabnis, and Andras Lacko, UNT Health Science Center, Fort Worth, TX



The overall goal of this study was to formulate and characterize reconstituted high density lipoprotein (rHDL) nanoparticles containing an imaging dye IR-780 iodide and assess its selective cytoplasmic delivery in prostate cancer cells. Although major advances have been made, prostate cancer still remains one of the most common cancers among men. Studies have shown that prostate-specific antigen (PSA) screening provides no precise method to determine, definitively, whether the cancers detected pose a serious life threat. rHDL-IR-780 nanoparticles were prepared by cholate dialysis method. The chemical composition of the nanoparticles was determined by BCA-protein assay, phospholipid and cholesterol were determined by respective assay kits. The size was determined by dynamic light scattering (DLS), by Beckman Coultar. The entrapment efficiency was determined spectrophotometrically at 780 nm. Cytoplasmic delivery of rHDL-IR-780 in prostate cancer cell line (DU-145) was monitored by confocal microscopy at Ex. 633 nm and Em. 750 nm. At 0.5 mg/mL, the entrapment efficiency of rHDL-IR-780 nanoparticles was found to be optimum at 79%. The average size of these was 46 nm. Indicating that 0.5 mg/ml was the optimal concentration for treatment. Stable, non-leaking, rHDL-IR-780 nanoparticles were successfully formulated. The intracellular uptake of IR-780 via SR-B1 receptors in DU 145 cell line indicated its promising potential in prostate cancer diagnostics. However, its use as a diagnostic tool in prostate cancer patients needs to be further analyzed in clinical settings.

Funder Acknowledgement(s): Funded by a Collaborative Undergraduate HBCU-STP grant PC150726 from the Department of Defense Prostate Cancer Research Program DOD-PCRP to Jamboor K. Vishwanatha, Wheels for Wellness, Inc. Fort Worth, TX, a grant awarded to Andras Lacko.

Faculty Advisor: Andras Lacko, andras.lacko@unthsc.edu

Role: My 10 week research project focused on the formulation and characterization of reconstituted high-density lipoproteins (rHDL) as well as the localization of an imaging agent within its core. My specific role in the project was to use the proper methods and conduct the experiments to get results that can be duplicated in further studies. These methods included cholate dialysis method, quenching and anisotrophy, as well as confocal imaging and spectrophotometer measurements. My research allowed me to standardize results in order for further research in this particular area.

Sidebar

Abstract Locators

  • Undergraduate Abstract Locator
  • Graduate Abstract Locator

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW
Washington,DC 20005
202-326-6400
Contact Us
About Us

  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube

The World’s Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

Focus Areas

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law

© 2023 American Association for the Advancement of Science